The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
1847 GOEDEKER INC *W EXP 99/99/999 28252C117 11,569 6,886,600 SH   SOLE   6,886,600 0 0
ACHIEVE LIFE SCIENCES INC COM 004468500 1,037 122,000 SH   SOLE   122,000 0 0
ADAMAS PHARMACEUTICALS INC COM 00548A106 3,071 625,469 SH   SOLE   625,469 0 0
ADICET BIO INC COM 007002108 1,116 142,289 SH   SOLE   142,289 0 0
AEGLEA BIOTHERAPEUTICS INC COM 00773J103 4,847 609,689 SH   SOLE   609,689 0 0
AFFIMED N V COM N01045108 4,110 665,000 SH   SOLE   665,000 0 0
ALDEYRA THERAPEUTICS INC COM 01438T106 7,586 864,020 SH   SOLE   864,020 0 0
ALIGOS THERAPEUTICS INC COM 01626L105 519 33,492 SH   SOLE   33,492 0 0
ALLENA PHARMACEUTICALS COM 018119107 963 1,067,886 SH   SOLE   1,067,886 0 0
APELLIS PHARMACEUTICALS INC COM 03753U106 5,494 166,700 SH Put SOLE   166,700 0 0
ARCTURUS THERAPEUTICS HLDGS COM 03969T109 3,822 80,000 SH   SOLE   80,000 0 0
ARCUTIS BIOTHERAPEUTICS INC COM 03969K108 6,092 255,000 SH   SOLE   255,000 0 0
ARYA SCIENCES ACQUISITN CORP CLASS A ORD SHS G31658100 1,005 100,000 SH   SOLE   100,000 0 0
AURINIA PHARMACEUTICALS INC COM 05156V102 3,187 144,000 SH   SOLE   144,000 0 0
AVADEL PHARMACEUTICALS PLC SPONSORED ADR 05337M104 4,318 440,589 SH   SOLE   440,589 0 0
AVIDITY BIOSCIENCES INC COM 05370A108 5,542 225,000 SH   SOLE   225,000 0 0
BCLS ACQUISITION CORP COM CL A G0904B105 996 100,000 SH   SOLE   100,000 0 0
BELLUS HEALTH INC NEW COM NEW 07987C204 10,983 1,788,789 SH   SOLE   1,788,789 0 0
BICYCLE THERAPEUTICS PLC SPONSORED ADS 088786108 3,826 92,000 SH   SOLE   92,000 0 0
BRIDGEBIO PHARMA INC COM 10806X102 3,703 79,000 SH   SOLE   79,000 0 0
CARDIFF ONCOLOGY INC COM 14147L108 2,324 348,888 SH   SOLE   348,888 0 0
CAREDX INC COM 14167L103 5,703 90,000 SH   SOLE   90,000 0 0
CASTLE BIOSCIENCES INC COM 14843C105 4,821 72,500 SH   SOLE   72,500 0 0
CELCUITY INC COM 15102K100 2,610 145,000 SH   SOLE   145,000 0 0
CELLDEX THERAPEUTICS INC NEW COM NEW 15117B202 9,988 185,000 SH   SOLE   185,000 0 0
CEREVEL THERAPEUTICS HLDNG I COM 15678U128 611 20,700 SH Put SOLE   20,700 0 0
CERUS CORP COM 157085101 6,699 1,100,000 SH   SOLE   1,100,000 0 0
CHAVANT CAPITAL ACQUISITN CO *W EXP 99/99/999 G2058L111 72 150,000 SH   SOLE   150,000 0 0
CHAVANT CAPITAL ACQUISITN CO ORDINARY SHARES G2058L103 1,970 200,000 SH   SOLE   200,000 0 0
CHIMERIX INC COM 16934W106 1,744 281,790 SH   SOLE   281,790 0 0
CHINOOK THERAPEUTICS INC COM 16961L106 5,933 465,000 SH   SOLE   465,000 0 0
CITIC CAPITAL ACQUISITION CO COM CL A G21513109 1,109 111,200 SH   SOLE   111,200 0 0
COLISEUM ACQUISITION CORP CLASS A ORD SHS G2263T123 846 85,000 SH   SOLE   85,000 0 0
COLOMBIER ACQUISITION CORP CL A 19533H108 484 50,000 SH   SOLE   50,000 0 0
COLOMBIER ACQUISITION CORP *W EXP 99/99/999 19533H116 9 16,666 SH   SOLE   16,666 0 0
CRINETICS PHARMACEUTICALS IN COM 22663K107 4,063 193,000 SH   SOLE   193,000 0 0
CTI BIOPHARMA CORP COM 12648L601 9,773 3,313,000 SH   SOLE   3,313,000 0 0
CURIS INC COM NEW 231269200 6,491 829,000 SH   SOLE   829,000 0 0
CYTOMX THERAPEUTICS INC COM 23284F105 6,279 1,233,642 SH   SOLE   1,233,642 0 0
DOUBLEDOWN INTERACTIVE CO LT ADS 25862B109 2,818 160,000 SH   SOLE   160,000 0 0
DYNE THERAPEUTICS INC COM 26818M108 2,706 166,636 SH   SOLE   166,636 0 0
EIGER BIOPHARMACEUTICALS INC COM 28249U105 1,319 197,500 SH   SOLE   197,500 0 0
ELOXX PHARMACEUTICALS INC COM 29014R103 1,822 1,118,000 SH   SOLE   1,118,000 0 0
EUCRATES BIOMEDICAL ACQU COR *W EXP 10/23/202 G3141W122 107 133,333 SH   SOLE   133,333 0 0
EUCRATES BIOMEDICAL ACQU COR SHS G3141W106 3,912 400,000 SH   SOLE   400,000 0 0
EYEPOINT PHARMACEUTICALS INC COM NEW 30233G209 3,861 370,551 SH   SOLE   370,551 0 0
FAT BRANDS INC *W EXP 07/16/202 30258N121 1,297 227,000 SH   SOLE   227,000 0 0
FIRSTMARK HORIZON ACQUISITIO CL A COM 33765Y101 980 100,000 SH   SOLE   100,000 0 0
FLUX PWR HLDGS INC COM NEW 344057302 2,652 521,972 SH   SOLE   521,972 0 0
FS DEVELOPMENT CORP II COM CL A 30318F100 1,990 200,000 SH   SOLE   200,000 0 0
GALERA THERAPEUTICS INC COM 36338D108 2,435 300,605 SH   SOLE   300,605 0 0
GIGINTERNATIONAL1 INC *W EXP 04/19/202 37518W114 37 50,000 SH   SOLE   50,000 0 0
GIGINTERNATIONAL1 INC COM 37518W106 1,974 200,000 SH   SOLE   200,000 0 0
GLOBUS MED INC CL A 379577208 2,950 38,500 SH   SOLE   38,500 0 0
HAEMONETICS CORP MASS COM 405024100 5,224 74,000 SH   SOLE   74,000 0 0
HARBOR CUSTOM DEVELOPMENT IN *W EXP 05/09/202 41150T116 351 600,000 SH   SOLE   600,000 0 0
HEALTH SCIENCES ACQ CORP 2 ORD SHS G4411D109 99 10,000 SH   SOLE   10,000 0 0
HEALTHCOR CATALIO ACQU CORP CL A SHS G44125105 1,980 200,000 SH   SOLE   200,000 0 0
HELIX ACQUISITION CORP COM CL A G4444C102 2,488 250,000 SH   SOLE   250,000 0 0
HILLMAN SOLUTIONS CORP COM 431636109 1,694 142,000 SH   SOLE   142,000 0 0
ICAD INC COM NEW 44934S206 3,440 320,000 SH   SOLE   320,000 0 0
IGM BIOSCIENCES INC COM 449585108 2,793 42,473 SH   SOLE   42,473 0 0
ILLUMINA INC COM 452327109 4,056 10,000 SH   SOLE   10,000 0 0
IMMATICS N.V *W EXP 07/01/202 N44445117 389 97,467 SH   SOLE   97,467 0 0
IMMATICS N.V SHS N44445109 6,227 478,987 SH   SOLE   478,987 0 0
INSMED INC COM PAR $.01 457669307 5,600 203,354 SH   SOLE   203,354 0 0
INSPIRE MED SYS INC COM 457730109 6,055 26,000 SH   SOLE   26,000 0 0
INSULET CORP COM 45784P101 1,208 4,250 SH   SOLE   4,250 0 0
IVERIC BIO INC COM 46583P102 5,328 328,101 SH   SOLE   328,101 0 0
JIYA ACQUISITION CORP COM CL A 47760M102 1,950 200,000 SH   SOLE   200,000 0 0
KALEYRA INC COM 483379103 5,335 484,592 SH   SOLE   484,592 0 0
KALVISTA PHARMACEUTICALS INC COM 483497103 1,952 111,834 SH   SOLE   111,834 0 0
KEROS THERAPEUTICS INC COM 492327101 4,985 126,000 SH   SOLE   126,000 0 0
KRYSTAL BIOTECH INC COM 501147102 303 5,800 SH Call SOLE   5,800 0 0
LAKESHORE ACQUISITION I CORP *W EXP 07/15/202 G53521111 79 150,000 SH   SOLE   150,000 0 0
LAKESHORE ACQUISITION I CORP ORDINARY SHARES G53521103 1,966 200,000 SH   SOLE   200,000 0 0
LANTHEUS HLDGS INC COM 516544103 7,447 290,000 SH   SOLE   290,000 0 0
LIFEMD INC COM 53216B104 1,793 288,700 SH   SOLE   288,700 0 0
MEI PHARMA INC COM NEW 55279B202 5,045 1,828,066 SH   SOLE   1,828,066 0 0
MEREO BIOPHARMA GROUP PLC ADS 589492107 3,025 1,250,000 SH   SOLE   1,250,000 0 0
MORPHIC HLDG INC COM 61775R105 3,398 60,000 SH   SOLE   60,000 0 0
MOTIVE CAPITAL CORP SHS CL A G6293A103 1,011 102,099 SH   SOLE   102,099 0 0
MYRIAD GENETICS INC COM 62855J104 5,102 158,000 SH   SOLE   158,000 0 0
NATERA INC COM 632307104 5,071 45,500 SH   SOLE   45,500 0 0
NEVRO CORP COM 64157F103 5,935 51,000 SH   SOLE   51,000 0 0
NOCTURNE ACQUISITION CORP ORDINARY SHARES G6580S114 4,990 500,000 SH   SOLE   500,000 0 0
NOCTURNE ACQUISITION CORP RIGHT 12/26/2025 G6580S106 210 500,000 SH   SOLE   500,000 0 0
OCULAR THERAPEUTIX INC COM 67576A100 5,560 556,000 SH   SOLE   556,000 0 0
OMEGA ALPHA SPAC CL A G6749V107 974 100,000 SH   SOLE   100,000 0 0
ONCORUS INC COM 68236R103 1,794 192,054 SH   SOLE   192,054 0 0
PHASEBIO PHARMACEUTICALS INC COM 717224109 2,410 775,000 SH   SOLE   775,000 0 0
PORTAGE BIOTECH INC COM G7185A128 1,524 75,000 SH   SOLE   75,000 0 0
POSEIDA THERAPEUTICS INC COM 73730P108 235 32,238 SH   SOLE   32,238 0 0
PROFOUND MED CORP COM NEW 74319B502 3,440 235,000 SH   SOLE   235,000 0 0
PROQR THRAPEUTICS N V SHS EURO N71542109 1,046 125,000 SH   SOLE   125,000 0 0
PROTAGONIST THERAPEUTICS INC COM 74366E102 6,131 346,000 SH   SOLE   346,000 0 0
RENOVACOR INC *W EXP 99/99/999 75989E114 501 731,561 SH   SOLE   731,561 0 0
RENOVACOR INC COM 75989E106 3,519 388,845 SH   SOLE   388,845 0 0
REPRO MED SYS INC COM 759910102 2,719 954,055 SH   SOLE   954,055 0 0
RESERVOIR MEDIA INC *W EXP 08/26/202 76119X113 99 50,000 SH   SOLE   50,000 0 0
SARISSA CAPITAL ACQUISITN CO *W EXP 10/23/202 G7823W110 75 75,000 SH   SOLE   75,000 0 0
SARISSA CAPITAL ACQUISITN CO CL A G7823W102 2,219 225,000 SH   SOLE   225,000 0 0
SCYNEXIS INC COM NEW 811292200 371 70,000 SH   SOLE   70,000 0 0
STRYVE FOODS INC CLASS A COM 863685103 1,070 200,000 SH   SOLE   200,000 0 0
SURROZEN INC *W EXP 08/01/203 86889P117 94 82,233 SH   SOLE   82,233 0 0
SYNDAX PHARMACEUTICALS INC COM 87164F105 2,064 108,000 SH   SOLE   108,000 0 0
SYROS PHARMACEUTICALS INC COM 87184Q107 5,688 1,272,412 SH   SOLE   1,272,412 0 0
TAILWIND ACQUISITION CORP COM CL A 87403Q102 1,256 128,414 SH   SOLE   128,414 0 0
TCR2 THERAPEUTICS INC COM 87808K106 503 59,150 SH   SOLE   59,150 0 0
TRACON PHARMACEUTICALS INC COM NEW 89237H209 3,039 785,341 SH   SOLE   785,341 0 0
TRAVERE THERAPEUTICS INC COM 89422G107 3,419 141,000 SH   SOLE   141,000 0 0
TURMERIC ACQUISITION CORP CL A G9127T108 2,487 254,000 SH   SOLE   254,000 0 0
TURMERIC ACQUISITION CORP *W EXP 10/08/202 G9127T124 55 84,666 SH   SOLE   84,666 0 0
UPHEALTH INC *W EXP 06/08/202 91532B119 5 10,000 SH   SOLE   10,000 0 0
VAREX IMAGING CORP COM 92214X106 4,456 158,000 SH   SOLE   158,000 0 0
VERASTEM INC COM 92337C104 6,939 2,253,000 SH   SOLE   2,253,000 0 0
VERRICA PHARMACEUTICALS INC COM 92511W108 3,203 256,244 SH   SOLE   256,244 0 0
VINCERX PHARMA INC COM NEW 92731L106 1,740 107,625 SH   SOLE   107,625 0 0
VIQ SOLUTIONS INC COM NEW 91825V400 2,086 704,687 SH   SOLE   704,687 0 0
VIRPAX PHARMACEUTICALS INC COM 928251107 1,305 271,846 SH   SOLE   271,846 0 0
X4 PHARMACEUTICALS INC COM 98420X103 4,256 804,598 SH   SOLE   804,598 0 0
XENON PHARMACEUTICALS INC COM 98420N105 3,300 216,000 SH   SOLE   216,000 0 0
XTANT MED HLDGS INC COM NEW 98420P308 6,942 6,254,458 SH   SOLE   6,254,458 0 0
YUMANITY THERAPEUTICS INC COM 98872L102 2,023 196,000 SH   SOLE   196,000 0 0